Petros Grivas: Excellent Session on GU Cancer Highlights Biomarkers and Treatment Personalization
Petros Grivas, Clinical Director of the GU cancers Program at the University of Washington, shared a post on X by Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, adding:
“Well said, Shilpa Gupta. Excellent session by Sia Daneshmand and Gopa with great speakers Vadim Koshkin, Fed Ghali, et al., and awesome patient advocate!
We need de-escalation and escalation trials, biomarkers for personalized approach on treatment duration, role of consolidation, etc.”
Quoting Shilpa Gupta’s post:
“An excellent session chaired by Sia Daneshmand, Gopaiyer on evolving strategies after EV-pembro in bladder cancer, Bladder Cancer Advocacy Network BCANTT25. Excellent multidisciplinary panel sharing insights.
Great to have a patient advocate at the table! A lot of unanswered questions re: consolidation survey, radiation approaches, managing local recurrences, etc.”
More posts featuring Petros Grivas on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023